JAC Advance Access originally published online on October 3, 2007
Journal of Antimicrobial Chemotherapy 2007 60(6):1402; doi:10.1093/jac/dkm379
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia
1 Intensive Care Department, Ghent University Hospital, Ghent, Belgium 2 Faculty of Medicine and Health Science, Ghent University, Ghent, Belgium 3 Faculty of Healthcare, University College Ghent, Ghent, Belgium 4 Infectious Diseases Department, Ghent University Hospital, Ghent, Belgium
* Correspondence address. Intensive Care Department, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. Tel: +32-9-240-62-16; Fax: +32-9-240-49-95; E-mail: stijn.blot@UGent.be
Keywords: bacteraemia , Escherichia spp. , antibiotic policy
| The first 10% of the full text of this article appears below. |
Sir,
We read with interest the article by Peralta et al.1 nicely outlining the relationships between multidrug resistance (MDR), decreased likelihood of appropriate empirical therapy and limited odds of survival. The authors concluded that continuing efforts should be aimed
Transparency declarations